Global Colorectal Cancer Molecular Diagnostics Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

The Colorectal Cancer Molecular Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Colorectal Cancer Molecular Diagnostics Market Size and Its Estimated Growth Rate?
The market for molecular diagnostics of colorectal cancer has seen notable expansion in recent years. The market size is anticipated to increase from $2.56 billion in 2024 to $2.77 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.1%. The significant growth observed in the historical period is largely due to factors such as the climbing rates of colorectal cancer cases, heightened awareness and screening campaigns, as well as a growing focus on personalized medicine, coupled with government initiatives designed to control cancer.

The market size for molecular diagnostics in colorectal cancer is forecasted to experience substantial growth in the forthcoming years. Projections show that it will expand to $3.79 billion by 2029, with a compound annual growth rate (CAGR) of 8.1%. This expansion in the prediction window can be credited to factors such as an aging population and heightened risk factors, the incorporation of genomic data into clinical routines, an increase in the use of precision medicine strategies, worldwide cancer research efforts, and collaborations. Key trends expected to be seen during this future period include a growing focus on early detection biomarkers, the application of artificial intelligence in data analysis, the emergence of circulating tumor DNA (CTDNA) analysis, the growth of companion diagnostics for targeted therapies, and a concentrated emphasis on immunotherapy biomarkers.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13120

How Are Emerging Segments Shaping the Colorectal Cancer Molecular Diagnostics Market Landscape?
The colorectal cancer molecular diagnostics market covered in this report is segmented -

1) By Type: Instruments, Reagents And Kits, Services
2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcription Mediated Amplification, Chips And Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT)
3) By End Users: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Homecare Settings

Subsegments:
1) By Instruments: PCR Machines, Sequencers, Microarrays
2) By Reagents And Kits: DNA Or RNA Extraction Kits, Assay Kits, Reagent Packs
3) By Services: Diagnostic Testing Services, Genetic Testing Services, Consultation Services

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13120&type=smp

Which Growth Factors Are Influencing Colorectal Cancer Molecular Diagnostics Market Expansion?
The escalating incidence of inflammatory bowel diseases (IBD), chronic gastrointestinal disorders characterised by inflammation in the digestive tract, predominantly the colon and , are predicted to drive the growth of the colorectal cancer molecular diagnostic market. With symptoms such as abdominal pain, diarrhoea, and weight loss, IBD is typically managed via medication, lifestyle adjustments, and occasionally surgery. Rising IBD incidence amplifies the necessity for precise, effective, and contemporary diagnostic solutions, given that systemic therapy decisions for colorectal cancer (CRC) largely rest upon the results derived from molecular analysis of the tumor. For example, in April 2024, the UK Parliament - a UK-based governing body - noted research from Crohn's & Colitis UK showing that the number of individuals in the UK living with IBD is 500,000, almost twice the previously estimated amount. Consequently, IBD's growing incidences will contribute to the expansion of the colorectal cancer molecular diagnostic market. The upswing in colorectal cancer prevalence is projected to fuel the growth of the colorectal cancer molecular diagnostics market. Colorectal cancer, affecting the colon or - parts of the digestive system - happens when uncontrolled cellular growth forms a tumor in these areas. The surge in colorectal cancer escalates the need for molecular diagnostics in cancer detection and treatment. To illustrate, as per the American Cancer Society, a US-based voluntary health organisation devoted to cancer eradication, in March 2023, roughly 153,020 individuals are predicted to be diagnosed with colorectal cancer, with an estimated 52,550 anticipated to succumb to the disease. Among these, approximately 19,550 cases and 3,750 deaths are projected to occur in individuals below age 50. Hence, the spiking prevalence of colorectal cancer is a key driver for the expansion of the colorectal cancer molecular diagnostics market.

Who Are the Dominant Players Across Different Colorectal Cancer Molecular Diagnostics Market Segments?
Major companies operating in the colorectal cancer molecular diagnostics market report are Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton inson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt.

What Trends Are Driving Growth in The Colorectal Cancer Molecular Diagnostics Market?
Leading businesses in the colorectal cancer molecular diagnostic market are concentrating their efforts on the creation of innovative molecular diagnostics and personalized medicine options, like the Shield Blood Test, to recognize colorectal cancer during its budding stage, when it is easier to treat. The Shield Blood Test is a preliminary blood examination aimed at identifying nascent colorectal cancer (CRC). For example, in May 2022, Guardant Health, an American biotechnology corporation offering molecular diagnostic products for oncology, introduced its Shield Blood Test. This sensitive shield exam offers an accessible screening alternative, requiring only a simple blood draw, to overcome barriers related to patient willingness to undergo screening. The exam demonstrated a 91% sensitivity rate for colorectal cancer detection and a 20% rate for detection of advanced adenomas, while specificity was recorded at 92%. By using data from diverse groups consisting of over 2000 colorectal cancer patients, 357 advanced adenoma patients, and 3757 healthy individuals, the Shield Test can identify early signs of colorectal cancer in the blood.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/colorectal-cancer-molecular-diagnostics-global-market-report

Which Geographic Regions Are Expected to Dominate the Colorectal Cancer Molecular Diagnostics Market in the Coming Years?
North America was the largest region in the colorectal cancer molecular diagnostics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Colorectal Cancer Molecular Diagnostics Market?
2. What is the CAGR expected in the Colorectal Cancer Molecular Diagnostics Market?
3. What Are the Key Innovations Transforming the Colorectal Cancer Molecular Diagnostics Industry?
4. Which Region Is Leading the Colorectal Cancer Molecular Diagnostics Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.